Ovo Labs has raised $5.4M in seed funding to develop therapeutics aimed at improving egg quality for IVF success. The round was backed by Local Globe and Creator Fund.

Get the full Ovo Labs company profile
Access contacts, investors, buying signals & more
Ovo Labs has raised $5.4M in seed funding to develop therapeutics aimed at improving egg quality for IVF success. The round was backed by Local Globe and Creator Fund.
$8 trillion. Thatâs UBS's forecast for the global longevity market by 2030. My bet: womenâs health could unlock some of its biggest breakthroughs.
Five companies expanding my longevity watchlist: â Gameto: engineered ovarian support cells to help eggs mature *outside* the body, with broader programs in ovarian disease and menopause. Ferring Pharmaceuticals' proposed acquisition: up to $1.38B. â Ovo Labs: targeting egg-quality defects that increase with age. The Max Planck spinout has 3 preclinical candidates & ÂŁ4M in seed funding co-led b

Quinn
Quinn helps frontline organizations standardize how their people train and perform. We turn the knowledge of your best people into training, simulations, assessments, and on-the-job resources that can be deployed across your workforce. Define what great looks like. Train people to that standard. Know who's ready to perform. Turn your best people into the Playbook.
$4.0M Seed
today

Ophthalmic Therapeutic Innovation
OTI is committed to harnessing cutting-edge science to create treatments that not only halt the progression of glaucoma but also improve the quality of life for patients worldwide. By integrating innovative research, patient insights, and clinical expertise, we strive to deliver breakthrough solutions that offer new hope and clearer vision to those affected by this challenging condition. Our dedication to excellence, transparency, and ethical practice drives our pursuit to lead the forefront of ophthalmic therapeutic innovation.
$250.0K Pre-seed
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Quinn | Seed | $4.0M | today |
| 2 | ![]() Physicl United States | Seed | $10.0M | today |
today
| $7.2B |
| 2y ago |
| 3 | ![]() GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 | ![]() Illumina United States | Unknown | $7.1B | 2y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
![]() encosa energy Germany |
| Seed |
| $28.1M |
| today |
| 4 | ![]() HighGround | Seed | $6.5M | today |
| 5 | ![]() ShopVision Canada | Seed | $4.1M | 1d ago |
Trusted by 200+ sales teams
Local Globe
VC FIRM
Creator Fund
VC
Reach Ovo Labs's investors directly from your dashboard.
Start free trial
Carbice
Recently received

SEDIPEC
Recently received

DMC Biotechnologies, Inc.
Recently received